Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
ExcellGene SA is a Monthey-based biotech services company that provides CHO-cell–based expression platforms for producing biotherapeutics, vaccine antigens, and related biologics at large scale. It partners with CEPI and international collaborators to develop a pan-protective SARS-CoV-2 vaccine using chimaeric antigens such as FRANKENSPIKE, with plans to advance to clinical trials. The group also markets its Magellan Biologics CHO4Tx transient expression platform, delivering high-titer antibody production and automation-ready workflows to accelerate development.
Parse Score